Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Sep;124(3):571-578.
doi: 10.1097/AOG.0000000000000412.

Perinatal outcomes associated with the diagnosis of gestational diabetes made by the international association of the diabetes and pregnancy study groups criteria

Affiliations
Comparative Study

Perinatal outcomes associated with the diagnosis of gestational diabetes made by the international association of the diabetes and pregnancy study groups criteria

John K Ethridge Jr et al. Obstet Gynecol. 2014 Sep.

Abstract

Objective: To assess perinatal outcomes with Carpenter-Coustan criteria for gestational diabetes mellitus (GDM), those with normal glucose testing, and those who would be added to GDM by The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criteria.

Methods: This was a retrospective cohort study of women who underwent screening and diagnostic testing for GDM. Patients were divided into nonoverlapping groups: GDM by Carpenter-Coustan (Carpenter-Coustan), IADPSG GDM criteria but not Carpenter-Coustan (IADPSG), and normal GDM screening or testing (control). Outcomes included newborn birth weight, birth weight z-score, Ponderal Index, and large for gestational age. Data were analyzed with one-way analysis of variance, t tests, or χ.

Results: There were 8,390 women who met inclusion criteria: 338 Carpenter-Coustan; 281 IADPSG; and 7,771 women in the control group. Mean birth weight (3,411 compared with 3,240 g, P<.01), birth weight z-score (0.477 compared with 0.059, P<.01), Ponderal Index (2.79 compared with 2.73 g/cm, P=.014), and large for gestational age (19.9% compared with 8.8%, relative risk 2.25, 95% confidence interval [CI] 1.76-2.88) were higher in IADPSG compared with women in the control group. The IADPSG group had greater birth weight (3,411 compared with 3,288 g, P<.01) than Carpenter-Coustan neonates with no difference in large for gestational age (19.9% compared with 16.0%, relative risk 1.25 95% CI 0.88-1.75), Ponderal Index (2.78 compared with 2.79 g/cm, P=1), or birth weight z-score (0.477 compared with 0.330, P=.30).

Conclusions: Newborns of women who would be added to the diagnosis of GDM by IADPSG criteria have greater measures of fetal overgrowth than those in the control group and greater birth weight in comparison with Carpenter-Coustan GDM neonates.

Level of evidence: II.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Patient allocation flow sheet. OGTT, oral glucose tolerance test. Ethridge. Perinatal Outcomes With Gestational Diabetes. Obstet Gynecol 2014.
Fig. 2
Fig. 2
Neonatal outcomes compared among women with diabetes according to the Carpenter-Coustan criteria, women who would be added by The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criteria, and women without gestational diabetes. Women with gestational diabetes per the Carpenter-Coustan criteria were treated with home fingerstick blood sugar testing, diet, and insulin if needed. Patients added to the gestational diabetes mellitus group by IADPSG criteria were typically untreated. The control group included patients with a normal 100-g, 3-hour oral glucose tolerance test or normal 50-g 1-hour glucose screen. P values shown for continuous variables are post hoc analysis of variance with the Tahmane method for multiple comparisons (three-group analysis of variance was used). P values for the categorical variable are χ2. *P value for Carpenter-Coustan group compared with control group. Ethridge. Perinatal Outcomes With Gestational Diabetes. Obstet Gynecol 2014.

References

    1. Gestational diabetes mellitus. Practice Bulletin No. 137. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2013;122:406–16. - PubMed
    1. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144:768–73. - PubMed
    1. O’Sullivan JB, Mahan C. Criteria for oral glucose tolerance test in pregnancy. Diabetes. 1964;13:278–85. - PubMed
    1. HAPO Study Cooperative Research Group. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002. - PubMed
    1. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–82. - PMC - PubMed

Publication types

MeSH terms